Ahmad Sazali Hamzah

Ahmad Sazali Hamzah

Auto-generated profile, based on publicly available information

Ahmad Sazali Hamzah

Universiti Teknologi MARA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2021 in Environmental Chemistry Letters
Verified
Journal Article
Closed access
PDF file
NRNur Aimi Aqilah Ahmad Ruslan
Nur Aimi Aqilah Ahmad Ruslan
SKSu‐Yin Kan
Su‐Yin Kan
AHAhmad Sazali Hamzah
Ahmad Sazali Hamzah
PCPoh Wai Chia
Poh Wai Chia

4 July 2021 in Journal of Receptors and Signal Transduction
Verified
Journal Article
Closed access
MIMUHD HANIS MD IDRIS
MUHD HANIS MD IDRIS
SASiti Norhidayah Mohd Amin
Siti Norhidayah Mohd Amin
SASiti Norhidayu Mohd Amin
Siti Norhidayu Mohd Amin
AWAgustono Wibowo
Agustono Wibowo
ZZZainul Amiruddin Zakaria
Zainul Amiruddin Zakaria
MSMOHD ZAKI SALLEH
MOHD ZAKI SALLEH
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely prescribed to treat inflammatory-related diseases, pain and fever. However, the prolong use of traditional NSAIDs leads to undesirable side effects such as gastric, ulceration, and renal toxicity due to lack of selectivity toward respective targets for COX-2, 5-LOX, and PDE4B. Thus, targeting multiple sites can reduce these adverse effects of the drugs and increase its potency. A series of methoxyflavones (F1–F5) were synthesized and investigated for their anti-inflammatory properties through molecular docking and inhibition assays. Among these flavones, only F2 exhibited selectivity toward COX-2 (Selectivity Index, SI: 3.90, COX-2 inhibition: 98.96 ± 1.47%) in comparison with celecoxib (SI: 7.54, COX-2 inhibition: 98.20 ± 2.55%). For PDEs, F3 possessed better selectivity to PDE4B (SI: 4.67) than rolipram (SI: 0.78). F5 had the best 5-LOX inhibitory activity among the flavones (33.65 ± 4.74%) but less than zileuton (90.81 ± 0.19%). Docking analysis indicated that the position of methoxy group and the substitution of halogen play role in determining the bioactivities of flavones. Interestingly, F1–F5 displayed favorable pharmacokinetic profiles and acceptable range of toxicity (IC50>70 µM) in cell lines with the exception for F1 (IC50: 16.02 ± 1.165 µM). This study generated valuable insight in designing new anti-inflammatory drug based on flavone scaffold. The newly synthesized flavones can be further developed as future therapeutic agents against inflammation. Graphical Abstract

1 September 2019 in Organic Communications
Verified
Journal Article
Closed access
FRFatin Nur Ain Abdul Rashid
Fatin Nur Ain Abdul Rashid
MMMohd Fazli Mohammat
Mohd Fazli Mohammat
ZSZurina i Shaamer
Zurina i Shaamer
HHHmad Sazali Hamzah
Hmad Sazali Hamzah
A new pathway for the synthesis of novel 3,4-fused pyrazolidinone-γ-lactam (4) starting from 2,3-dioxo-4-carboxy-5-(substituted)pyrrolidines (1) was developed. The key synthetic strategy involved hydrazonation of the precursor 1 followed by subsequent reduction reaction of the enamino ester 2 and intramolecular cyclization reaction to furnish the unprecedented 3,4-fused pyrazolidinone-γ- lactam (4) in reasonable yield. The structures of all synthesized compounds were confirmed by spectroscopic methods and chemical transformation.

1 December 2020 in Journal of Molecular Liquids
Verified
Journal Article
Closed access
SSSabahat Sardar
Sabahat Sardar
EJErum Jabeen
Erum Jabeen
PWProf Dr Cecilia Devi Wilfred
Prof Dr Cecilia Devi Wilfred
AHAhmad Sazali Hamzah
Ahmad Sazali Hamzah
JLJean Marc Leveque
Jean Marc Leveque

27 September 2020 in Organic Communications
Verified
Journal Article
Closed access
AWAgustono Wibowo
Agustono Wibowo
ZSZurina Shaameri
Zurina Shaameri
MMMohd Fazli Mohammat
Mohd Fazli Mohammat
AHAhmad Sazali Hamzah
Ahmad Sazali Hamzah
Some novel five-membered iminosugar analogues were efficiently synthesized via the MCRs of three components; amines, aldehydes and oxaloacetate to give 4-hydroxymethylpyrrolidines. Reduction of 3-hydroxy-4-carbomethoxy-3-pyrroliden-2-ones with Pd/C-catalyzed hydrogenation gave the corresponding cis-hydrogenated products at C3/C4 stereoselectively. Then following reductions of ester and amide functionalities with LiAlH4 afforded 4-(hydroxymethyl)pyrrolidin-3-ols. Among the synthesized compounds 4-hydrazineyl-3-hydroxymethyl-2-(4-methoxyphenyl)-N-methylpyrrolidine and 3-hydrazineyl-4-hydroxymethyl-1-methylpyrrolidine were found to be the most promising a-glucosidase inhibitor with IC50 values of 1.12 and 1.17 mM, respectively.

29 March 2017 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
TRThirumurugan Rathinasabapathy
Thirumurugan Rathinasabapathy
KJKimberly Marie Palatini Jackson
Kimberly Marie Palatini Jackson
YTYiwen Thor
Yiwen Thor
SASunday Buru Ayuba
Sunday Buru Ayuba
Debora EspositoDebora Esposito
Debora Esposito
Slavko KomarnytskySlavko Komarnytsky
Slavko Komarnytsky
Background. Glucocorticoid excess has been linked to clinical observations associated with the pathophysiology of metabolic syndrome. The intracellular glucocorticoid levels are primarily modulated by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme that is highly expressed in key metabolic tissues including fat, liver, and the central nervous system. Methods. In this study we synthesized a set of novel tetrahydrothiazolopyridine derivatives, TR-01–4, that specifically target 11β-HSD1 and studied their ability to interfere with the glucocorticoid and lipid metabolism in the 3T3-L1 adipocytes. Results. Based on the docking model and structure-activity relationships, tetrahydrothiazolopyridine derivatives TR-02 and TR-04 showed the highest potency against 11β-HSD1 by dose-dependently inhibiting conversion of cortisone to cortisol (IC50 values of 1.8 μM and 0.095 μM, resp.). Incubation of fat cells with 0.1–10 μM TR-01–4 significantly decreased cortisone-induced lipid accumulation in adipocytes and suppressed 11β-HSD1 mRNA expression. Observed reduction in adipocyte fat stores could be partially explained by decreased expression levels of adipogenic markers (PPAR-γ, aP2) and key enzymes of lipid metabolism, including fatty acid synthase (FAS), hormone sensitive lipase (HSL), and lipoprotein lipase (LPL). Conclusions. The tetrahydrothiazolopyridine moiety served as an active pharmacophore for inhibiting 11β-HSD1 and offered a novel therapeutic strategy to ameliorate metabolic alterations found in obesity and diabetes.